Fig. 1.

Study design. Data for this study were collected in two phases. In phase 1, panel participants were screened for the presence of symptoms, past treatment, and a diagnosis of Dupuytren’s disease. In phase 2, eligibility to complete the full survey was determined by participants’ responses to the screening items in phase 1. ^aParticipants for the Dupuytren’s phase 2 subsample populations were selected from the phase 2 eligible participants population to meet predetermined sample sizes